Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: AZD4076
Study Purpose: This study was done to learn how
AZD4076 works and about its
safety in participants with type 2
diabetes who have
non-alcoholic fatty liver
disease.
Protocol Number: D5590C00002
Thank you!
Thank you for taking part in the clinical study for the study drug AZD4076.
AstraZeneca sponsored this study and believes it is important to share the results.
An independent non-profit organization called CISCRP helped prepare this
summary of the study results for you.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
This study happened in 3 groups. This summary shows the results from Group 3.
The results from Groups 1 and 2 are in different summaries.
1